Literature DB >> 14769288

Brucellosis and international travel.

Ziad A Memish1, Hanan H Balkhy.   

Abstract

Brucellosis is a zoonotic disease of worldwide distribution that mainly affects persons working with domestic animals and animal products. Despite being controlled in many developed countries, the disease remains endemic in many parts of the world, including Latin America, the Middle East, Spain, parts of Africa, and western Asia. The disease is mainly transmitted to humans through the ingestion of raw milk or non-pasteurized cheese contaminated with one of the four Brucella species pathogenic to humans. The clinical presentation can vary from asymptomatic infection with seroconversion to a full-blown clinical picture of fever, night sweats and joint manifestations; rarely, there is hepatic, cardiac, ocular or central nervous system involvement. Since travelers may be affected, travel health physicians need to know the clinical presentation of patients with brucellosis and preventive strategies.

Entities:  

Mesh:

Year:  2004        PMID: 14769288     DOI: 10.2310/7060.2004.13551

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  43 in total

1.  Altered Transcriptome of the B. melitensis Vaccine Candidate 16MΔvjbR, Implications for Development of Genetically Marked Live Vaccine.

Authors:  Yuehua Ke; Yufei Wang; Xitong Yuan; Zhijun Zhong; Qing Qu; Dongsheng Zhou; Xiaotao Zeng; Jie Xu; Zhoujia Wang; Xinying Du; Tongkun Wang; Ruifu Yang; Qing Zhen; Yaqin Yu; Liuyu Huang; Zeliang Chen
Journal:  Indian J Microbiol       Date:  2012-08-02       Impact factor: 2.461

2.  Prevalence and risk factors of brucellosis among veterinary health care professionals.

Authors:  Rajeswari Shome; Triveni Kalleshamurthy; Padmashree B Shankaranarayana; Prashanth Giribattanvar; Nagarathna Chandrashekar; Nagalingam Mohandoss; Bibek Ranjan Shome; Ashok Kumar; Sukhadeo B Barbuddhe; Habibur Rahman
Journal:  Pathog Glob Health       Date:  2017-07-08       Impact factor: 2.894

3.  Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.

Authors:  Neeta Jain-Gupta; Araceli Contreras-Rodriguez; Ramesh Vemulapalli; Sharon G Witonsky; Stephen M Boyle; Nammalwar Sriranganathan
Journal:  FEMS Immunol Med Microbiol       Date:  2012-12

4.  Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003.

Authors:  S Al Dahouk; K Nöckler; A Hensel; H Tomaso; H C Scholz; R M Hagen; H Neubauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

5.  Evaluation of Regulatory T Cells in Patients with Acute and Chronic Brucellosis.

Authors:  Ali Ganji; Ghasem Mosayebi; Ehsanollah Ghaznavi-Rad; Khadije Khosravi; Nader Zarinfar
Journal:  Rep Biochem Mol Biol       Date:  2017-04

6.  Treatment of brucellosis: a systematic review of studies in recent twenty years.

Authors:  Seyed Mohammad Alavi; Leila Alavi
Journal:  Caspian J Intern Med       Date:  2013

7.  Bartonella and Brucella--weapons and strategies for stealth attack.

Authors:  Houchaima Ben-Tekaya; Jean-Pierre Gorvel; Christoph Dehio
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

Review 8.  Dairy goat production systems: status quo, perspectives and challenges.

Authors:  Luis Escareño; Homero Salinas-Gonzalez; Maria Wurzinger; Luiz Iñiguez; Johann Sölkner; Cesar Meza-Herrera
Journal:  Trop Anim Health Prod       Date:  2012-08-14       Impact factor: 1.559

9.  Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Authors:  Marina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

10.  Changing epidemiology of human brucellosis, Germany, 1962-2005.

Authors:  Sascha Al Dahouk; Heinrich Neubauer; Andreas Hensel; Irene Schöneberg; Karsten Nöckler; Katharina Alpers; Hiltrud Merzenich; Klaus Stark; Andreas Jansen
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.